Dauntless Investment Group »

Cue Biopharma shares owned by Dauntless Investment Group

Quarter-by-quarter ownership of Cue Biopharma shares owned by Dauntless Investment Group from 13F filings

Historical chart of Dauntless Investment Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Dauntless Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Dauntless Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $554 2.4k 0.23

More positions owned by Dauntless Investment Group

Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)
Select Sector Spdr Tr State Street Con Put Option (XLY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
Ishares Tr China Lg-cap Etf Call Option (FXI)
Innoviva (INVA)
Femasys (FEMY)
Tiziana Life Sciences Common Shares (TLSA)
Aeon Biopharma Cl A New (AEON)
Lincoln Educational Services Corporation (LINC)
Coursera (COUR)
St. Joe Company (JOE)
Profound Med Corp Com New (PROF)
Oncology Institu (TOI)

View all positions for Dauntless Investment Group

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Capital Management
Lion Point Capital
Geode Capital Management
Vanguard Fiduciary Trust
Robertson Stephens Wealth Management
BlackRock
Texas Capital Bank Wealth Management Services
Angeles Wealth Management
Advisory Research
Stifel Financial
Renaissance Technologies
Bank of America Corporation
State Street Corporation

View all funds holding Cue Biopharma